๐ข ๐๐๐๐ ๐๐: Eli Lilly Plans Europe Launch of Weight-Loss Pill in Late 2026 or Early 2027 - $Eli Lilly(LLY.US) $Novo Nordisk AS(NVO.US) $Hims & Hers Health(HIMS.US)
๐ ๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:โค ๐๐ฅ๐ข ๐๐ข๐ฅ๐ฅ๐ฒ plans to launch its weight-loss pill in Europe and Britain in ๐๐ ๐๐๐๐ or early ๐๐๐๐.โค Launch timing depends on obtaining ๐ซ๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ approvals across target markets.โค Lilly will initially target the ๐จ๐ฎ๐ญ-๐จ๐-๐ฉ๐จ๐๐ค๐๐ญ telehealth market.โค Strategy mirrors Lilly's ๐.๐. direct-to-consumer obesity business model.โค The company plans partnerships with ๐ญ๐๐ฅ๐๐ก๐๐๐ฅ๐ญ๐ก providers and digital health platforms.โค Lilly says obesity treatment outside the U.S. is largely ๐ฉ๐๐ญ๐ข๐๐ง๐ญ-๐ฉ๐๐ข๐.โค The drug recently secured approvals in the ๐.๐. and ๐๐๐.โค Lilly will continue pursuing ๐ ๐จ๐ฏ๐๐ซ๐ง๐ฆ๐๐ง๐ญ reimbursement where available.โค U.S. ๐ฆ๐จ๐ฌ๐ญ-๐๐๐ฏ๐จ๐ฎ๐ซ๐๐-๐ง๐๐ญ๐ข๐จ๐ง pricing policies may affect negotiations.๐ ๐๐ก๐ฒ ๐๐ญ ๐๐๐ญ๐ญ๐๐ซ๐ฌ:โค Expands Lilly's presence in the rapidly growing ๐ ๐ฅ๐จ๐๐๐ฅ obesity treatment market.โค Telehealth-focused distribution could accelerate ๐ฉ๐๐ญ๐ข๐๐ง๐ญ access and adoption.โค European expansion may create a significant new ๐ซ๐๐ฏ๐๐ง๐ฎ๐ opportunity for Lilly.๐ ๐๐ฑ๐ฉ๐๐ซ๐ญ ๐๐ญ๐๐ญ๐๐ฆ๐๐ง๐ญ:โค "Our goal will still be public coverage, wherever possible." โ ๐๐๐ญ๐ซ๐ข๐ค ๐๐จ๐ง๐ฌ๐ฌ๐จ๐ง, Executive Vice President of Lilly's International Businesses.โค "MFN will play a role for all launches." โ ๐๐๐ญ๐ซ๐ข๐ค ๐๐จ๐ง๐ฌ๐ฌ๐จ๐ง.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments